Robert C Millikan
Biographic Data
| ID | 6056863 |
|---|---|
| NAME | Robert C Millikan |
| GIVEN NAMES | Robert C |
| FAMILY NAME | Millikan |
| SIGNATURE | MILLIKAN R C |
| AFFILIATIONS | University of North Carolina at Chapel Hill |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 20 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1999 |
| LATEST PUBLICATION YEAR | 2005 |
| H-INDEX | 2 |
Genomics and the Public Health Code of Ethics
We consider the public health applications of genomic technologies as viewed through the lens of the public health code of ethics. We note, for example, the potential for genomics to increase our appreciation for the public health value of interdependence, the potential for some genomic tools to exacerbate health disparities because of their inaccessibility by the poor and the way in which genomics forces public health to refine its notions of pr…
Development and implementation of a science training course for breast cancer activists
Objective To develop and implement Project LEAD (leadership, education, and advocacy development), a science course for breast cancer activists. Population Students were breast cancer activists and other consumers, mainly affiliated with advocacy organizations in the United States of America. Setting Project LEAD is offered by the National Breast Cancer Coalition; the course takes place over 5 days and is offered 4 times a year, in various cities…
Vitamin supplement use and breast cancer in a North Carolina population
Objective: Laboratory data suggest that several different vitamins may inhibit the growth of mammary cancers, however epidemiologic data on the relationship between vitamin supplement use and breast cancer are inconsistent. We examined the association between self-reported vitamin supplement use and breast cancer among black women and white women. Design and setting: The data came from a population-based, case–control study conducted in North Car…
Area-Level Characteristics and Smoking in Women
Objectives. This study examined whether area-level characteristics are associated with individual smoking behavior among women. Methods. Analyses included 648 women enrolled as control patients in the Carolina Breast Cancer Study (1993–1996). Smoking and covariate information was obtained from interviews. Area-level characteristics included census block-group education level, poverty, unemployment, car–home ownership, crowding, and, for 431 women…
Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
Objective To determine if blood levels of 25-hydroxyvitamin D (25-D) or its active metabolite, 1,25-dihydroxyvitamin D (1,25-D), are lower in women at the time of first diagnosis of breast cancer than in comparable women without breast cancer. Design This was a clinic-based case–control study with controls frequency-matched to cases on race, age, clinic and month of blood drawing. Setting University-based breast referral clinics. Subjects One hun…
Area-Level Characteristics and Smoking in Women
Objectives. This study examined whether area-level characteristics are associated with individual smoking behavior among women. Methods. Analyses included 648 women enrolled as control patients in the Carolina Breast Cancer Study (1993–1996). Smoking and covariate information was obtained from interviews. Area-level characteristics included census block-group education level, poverty, unemployment, car–home ownership, crowding, and, for 431 women…
Genomics and the Public Health Code of Ethics
We consider the public health applications of genomic technologies as viewed through the lens of the public health code of ethics. We note, for example, the potential for genomics to increase our appreciation for the public health value of interdependence, the potential for some genomic tools to exacerbate health disparities because of their inaccessibility by the poor and the way in which genomics forces public health to refine its notions of pr…
Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
Objective To determine if blood levels of 25-hydroxyvitamin D (25-D) or its active metabolite, 1,25-dihydroxyvitamin D (1,25-D), are lower in women at the time of first diagnosis of breast cancer than in comparable women without breast cancer. Design This was a clinic-based case–control study with controls frequency-matched to cases on race, age, clinic and month of blood drawing. Setting University-based breast referral clinics. Subjects One hun…
Development and implementation of a science training course for breast cancer activists
Objective To develop and implement Project LEAD (leadership, education, and advocacy development), a science course for breast cancer activists. Population Students were breast cancer activists and other consumers, mainly affiliated with advocacy organizations in the United States of America. Setting Project LEAD is offered by the National Breast Cancer Coalition; the course takes place over 5 days and is offered 4 times a year, in various cities…
Vitamin supplement use and breast cancer in a North Carolina population
Objective: Laboratory data suggest that several different vitamins may inhibit the growth of mammary cancers, however epidemiologic data on the relationship between vitamin supplement use and breast cancer are inconsistent. We examined the association between self-reported vitamin supplement use and breast cancer among black women and white women. Design and setting: The data came from a population-based, case–control study conducted in North Car…
Area-Level Characteristics and Smoking in Women
Objectives. This study examined whether area-level characteristics are associated with individual smoking behavior among women. Methods. Analyses included 648 women enrolled as control patients in the Carolina Breast Cancer Study (1993–1996). Smoking and covariate information was obtained from interviews. Area-level characteristics included census block-group education level, poverty, unemployment, car–home ownership, crowding, and, for 431 women…
Genomics and the Public Health Code of Ethics
We consider the public health applications of genomic technologies as viewed through the lens of the public health code of ethics. We note, for example, the potential for genomics to increase our appreciation for the public health value of interdependence, the potential for some genomic tools to exacerbate health disparities because of their inaccessibility by the poor and the way in which genomics forces public health to refine its notions of pr…
Medicine (5 works) · Breast cancer (3 works) · Cancer (3 works) · Confidence interval (2 works) · Environmental health (2 works) · Global Cancer Incidence and Screening (2 works) · Gynecology (2 works) · Internal Medicine (2 works) · Odds ratio (2 works) · Alternative medicine (1 work)